Nexien BioPharma (NXEN) Total Assets by Year
Nexien BioPharma Inc closed fiscal year 2024 with $4K in total assets, $365K in total liabilities and -$361K in shareholder equity. Total assets fell 90.3% from the prior fiscal year. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Nexien BioPharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NXEN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing | FY14Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4K-90.3% | $43K-65.4% | $125K+387.5% | $26K+12.1% | $23K-92.7% | $311K-75.6% | $1.3M+64.4% | $774Kn/m | $0n/m | $0n/m | $0 |
| Total Liabilities | $365K+23.8% | $295K+21.9% | $242K+515.8% | $39K+34.9% | $29K-34.9% | $45K-49.6% | $89K-3.0% | $92K+31.0% | $70K+42.9% | $49K+10006.4% | $484 |
| Total Equity | -$361Kn/m | -$252Kn/m | -$118Kn/m | -$14Kn/m | -$6K-102.4% | $266K-77.5% | $1.2M+110.1% | $563Kn/m | -$70Kn/m | -$49Kn/m | -$484 |
NXEN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing | Q1'23Filing | Q4'22Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8K-41.9% | $1K-50.1% | $5K-77.5% | $4K-90.3% | $14K-75.5% | $3K-96.6% | $22K-79.0% | $43K-65.4% | $58K-59.6% | $77K+2516.3% | $105K+1310.0% | $125K+387.5% |
| Total Liabilities | $459K+35.1% | $424K+33.8% | $397K+26.8% | $365K+23.8% | $340K+17.7% | $317K+13.4% | $313K+17.8% | $295K+21.9% | $288K+39.2% | $279K+327.3% | $266K+459.9% | $242K+515.8% |
| Total Equity | -$451Kn/m | -$423Kn/m | -$392Kn/m | -$361Kn/m | -$325Kn/m | -$314Kn/m | -$291Kn/m | -$252Kn/m | -$230Kn/m | -$202Kn/m | -$161Kn/m | -$118Kn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Nexien BioPharma Inc financials
Frequently Asked Questions
Nexien BioPharma Inc closed fiscal year 2024 with $4K in total assets, $365K in total liabilities and -$361K in shareholder equity.
Nexien BioPharma Inc (NXEN) total assets fell by 90.3% year over year, from $43K to $4K in fiscal year 2024.
Across the 11 fiscal years this page covers, Nexien BioPharma Inc (NXEN) total assets went from $0 in fiscal year 2014 to $4K in fiscal year 2024.
Nexien BioPharma Inc (NXEN) reported $8K in total assets in Q3 2025. This represents a decrease of 41.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Nexien BioPharma Inc (NXEN) reported on that line in every period on record.